000			01674 a2200457 4500
005			20250517060409.0
264		0	_c20160926
008			201609s 0 0 eng d
022			_a1873-1708
024	7		_a10.1016/j.reprotox.2015.10.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aClarke, D O
245	0	0	_aAssessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys. _h[electronic resource]
260			_bReproductive toxicology (Elmsford, N.Y.) _cDec 2015
300			_a160-73 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAge Factors
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal, Humanized _xtoxicity
650	0	4	_aBiomarkers _xblood
650	0	4	_aEmbryonic Development _xdrug effects
650	0	4	_aFemale
650	0	4	_aFertility _xdrug effects
650	0	4	_aFetal Development _xdrug effects
650	0	4	_aFetus _xdrug effects
650	0	4	_aGestational Age
650	0	4	_aImmune System _xdrug effects
650	0	4	_aImmunologic Factors _xtoxicity
650	0	4	_aMacaca fascicularis
650	0	4	_aMale
650	0	4	_aPregnancy
650	0	4	_aPrenatal Exposure Delayed Effects
650	0	4	_aReproduction _xdrug effects
650	0	4	_aRisk Assessment
700	1		_aHilbish, K G
700	1		_aWaters, D G
700	1		_aNewcomb, D L
700	1		_aChellman, G J
773	0		_tReproductive toxicology (Elmsford, N.Y.) _gvol. 58 _gp. 160-73
856	4	0	_uhttps://doi.org/10.1016/j.reprotox.2015.10.008 _zAvailable from publisher's website
999			_c25369245 _d25369245